Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: A molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues

被引:85
作者
Poremba, C
Scheel, C
Hero, B
Christiansen, H
Schaefer, KL
Nakayama, J
Berthold, F
Juergens, H
Boecker, W
Dockhorn-Dworniczak, B
机构
[1] Univ Munster, Gerhard Domagk Inst Pathol, D-48149 Munster, Germany
[2] Univ Munster, Dept Pediat Hematol & Oncol, D-48149 Munster, Germany
[3] Univ Cologne, Dept Pediat Hematol, Cologne, Germany
[4] Univ Cologne, Dept Oncol, Cologne, Germany
[5] Univ Marburg, Marburg, Germany
[6] Cold Spring Harbor Lab, New York, NY USA
[7] Tokyo Inst Technol, Dept Life Sci, Yokohama, Kanagawa 227, Japan
关键词
D O I
10.1200/JCO.2000.18.13.2582
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: We have recently demonstrated that telomerase activity (TA) is an independent prognostic factor in neuroblastomas. in the present study, the prognostic impact of TA and gene expression of the three major telomerase subunits is evaluated by molecular and immunohistochemical techniques in fresh-frozen and paraffin-embedded tissues. Patients and Methods: One hundred thirty-three neuroblastomas of all stages were analyzed for TA, The TA levels of 75 neuroblastoma cases were correlated with gene expression of telomerase subunits hTRT, human telomerase RNA (hTR), and telomerase protein 1 (TP1) by quantitative reverse transcriptase polymerase chain reaction (RT-PCR), using an innovative approach on the LightCycler instrument (Roche Diagnostics, Mannheim, Germany). For selected cases, the applicability of RT-PCR and immunohistochemistry for hTRT expression analysis was investigated in paraffin-embedded tissues. TA and subunit expression patterns were correlated with traditional prognostic indicators and disease outcome. Results: TA was present in a total of 39 (29.3%) of 133 neuroblastomas and in 31 (29.8%) of 104 initial neuroblastomas without cytotoxic pretreatment, TA was significantly correlated with both event-free and overall survival (P <.0001), Furthermore, we found a significant correlation between expression levels of TA and hTRT (P <.0001) as well as hTR (P <.001), Multivariate analysis revealed only TA and tumor stage but not serum lactate dehydrogenase, MYCN amplification, or age at diagnosis as independent prognostic factors. Conclusion: The significant correlation with clinical outcome strongly recommends that analysis of TA be incorporated into the clinical investigation of each individual neuroblastoma at the time of diagnosis. Because the mere presence or absence of TA without further quantification is sufficient basis for predicting disease outcome, the telomeric repeat amplification protocol assay could be complemented with but not replaced by analysis of hTRT or hTR expression. J Clin Oncol 18:2582-2592, (C) 2000 by American Society of Clinical Oncology.
引用
收藏
页码:2582 / 2592
页数:11
相关论文
共 42 条
  • [11] Hisatomi H, 1999, INT J ONCOL, V14, P727
  • [12] Hiyama E, 1999, CLIN CANCER RES, V5, P601
  • [13] LENGTH OF TELOMERIC REPEATS IN NEUROBLASTOMA - CORRELATION WITH PROGNOSIS AND OTHER BIOLOGICAL CHARACTERISTICS
    HIYAMA, E
    HIYAMA, K
    YOKOYAMA, T
    ICHIKAWA, T
    MATSUURA, Y
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (02): : 159 - 164
  • [14] CORRELATING TELOMERASE ACTIVITY LEVELS WITH HUMAN NEUROBLASTOMA OUTCOMES
    HIYAMA, E
    HIYAMA, K
    YOKOYAMA, T
    MATSUURA, Y
    PIATYSZEK, MA
    SHAY, JW
    [J]. NATURE MEDICINE, 1995, 1 (03) : 249 - 255
  • [15] Overexpression of human telomerase RNA is an early event in oesophageal carcinogenesis
    Hiyama, T
    Yokozaki, H
    Kitadai, Y
    Haruma, K
    Yasui, W
    Kajiyama, G
    Tahara, E
    [J]. VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1999, 434 (06): : 483 - 487
  • [16] Ito H, 1998, CLIN CANCER RES, V4, P1603
  • [17] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS
    KAPLAN, EL
    MEIER, P
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481
  • [18] Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: The Pediatric Oncology Group experience - A Pediatric Oncology Group study
    Katzenstein, HM
    Bowman, LC
    Brodeur, GM
    Thorner, PS
    Joshi, VV
    Smith, EI
    Look, AT
    Rowe, ST
    Nash, MB
    Holbrook, T
    Alvarado, C
    Rao, PV
    Castleberry, RP
    Cohn, SL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) : 2007 - 2017
  • [19] Maitra A, 1999, CANCER-AM CANCER SOC, V85, P741, DOI 10.1002/(SICI)1097-0142(19990201)85:3<741::AID-CNCR25>3.0.CO
  • [20] 2-6